0,974  0,001  Antihypercholesterolemic
0,955  0,001  Cholesterol antagonist
0,932  0,001  Antihyperlipoproteinemic
0,927  0,001  UGT1A4 substrate
0,925  0,004  Carcinogenic
0,914  0,003  Teratogen
0,910  0,002  NOS3 expression inhibitor
0,908  0,004  Embryotoxic
0,899  0,004  TNF expression inhibitor
0,895  0,001  UGT2B1 substrate
0,897  0,003  CYP2C19 substrate
0,883  0,005  CYP3A4 substrate
0,873  0,004  Respiratory analeptic
0,872  0,003  Chemopreventive
0,855  0,002  Hair growth stimulant
0,853  0,002  Sulfotransferase substrate
0,848  0,009  Antiinflammatory
0,828  0,003  Anesthetic
0,827  0,004  Bone diseases treatment
0,817  0,003  Proliferative diseases treatment
0,809  0,001  Anticataract
0,811  0,004  CTGF expression inhibitor
0,806  0,000  Cholesterol synthesis inhibitor
0,807  0,002  Anesthetic general
0,806  0,001  Pregnane X receptor agonist
0,814  0,015  Apoptosis agonist
0,802  0,004  Antiosteoporotic
0,793  0,004  Hepatic disorders treatment
0,790  0,006  Chemoprotective
0,774  0,005  Lipoprotein disorders treatment
0,758  0,001  UGT2B4 substrate
0,762  0,005  Analeptic
0,753  0,001  UGT2B7 substrate
0,744  0,006  Sensitization
0,754  0,017  Caspase 9 stimulant
0,739  0,017  Transcription factor NF kappa B inhibitor
0,725  0,003  Prostatic (benign) hyperplasia treatment
0,721  0,002  Autism spectrum disorders treatment
0,720  0,004  UDP-glucuronosyltransferase substrate
0,717  0,011  CYP2C9 substrate
0,703  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,699  0,003  Antipruritic, allergic
0,692  0,005  UGT1A1 substrate
0,687  0,003  Retinoprotector
0,685  0,004  Amyotrophic lateral sclerosis treatment
0,677  0,006  UGT1A6 substrate
0,667  0,003  Androgen antagonist
0,656  0,007  Antipsoriatic
0,640  0,005  Hypolipemic
0,643  0,010  Atherosclerosis treatment
0,627  0,002  Liver X receptor alpha agonist
0,622  0,008  Apoptosis antagonist
0,633  0,022  Antidiabetic
0,633  0,022  Cyclophilin D inhibitor
0,614  0,009  Inflammatory Bowel disease treatment
0,607  0,011  Cytotoxic
0,603  0,010  NOS2 expression inhibitor
0,603  0,013  Immunosuppressant
0,588  0,001  5-Alpha-reductase 2 inhibitor
0,590  0,004  Phospholipase C inhibitor
0,601  0,016  Immunostimulant
0,613  0,033  Antineoplastic (breast cancer)
0,584  0,004  Amylase inhibitor
0,581  0,002  Abortion inducer
0,582  0,005  UGT1A3 substrate
0,594  0,019  Prostate cancer treatment
0,577  0,004  Hedgehog signaling inhibitor
0,576  0,003  Interferon gamma antagonist
0,573  0,002  Sodium/bile acid cotransporter inhibitor
0,583  0,013  Immunomodulator
0,578  0,009  Metabolic disease treatment
0,577  0,013  Antiepileptic
0,560  0,001  5-Alpha-reductase 1 inhibitor
0,564  0,005  Hepatoprotectant
0,560  0,004  Antiacne
0,554  0,001  5-Alpha-reductase inhibitor
0,551  0,003  Prostate disorders treatment
0,540  0,005  Interleukin 2 agonist
0,544  0,015  Antifungal
0,532  0,005  Contraceptive
0,531  0,006  Diuretic
0,527  0,003  Antiinfertility, female
0,521  0,003  UGT2B9 substrate
0,527  0,009  Sedative
0,527  0,019  Antineoplastic (pancreatic cancer)
0,509  0,002  Antipruritic, non-allergic
0,512  0,008  Antineoplastic (liver cancer)
0,506  0,004  DNA polymerase I inhibitor
0,503  0,004  Lipocortins synthesis antagonist
0,504  0,009  Interleukin agonist
0,490  0,005  Antiparkinsonian, rigidity relieving
0,480  0,014  Renal disease treatment
0,469  0,003  Contraceptive female
0,485  0,023  AR expression inhibitor
0,473  0,018  Nitric oxide antagonist
0,457  0,005  Growth factor agonist
0,473  0,022  Antihypertensive
0,479  0,030  Antineoplastic (ovarian cancer)
0,450  0,002  Androgen agonist
0,446  0,002  Bile acid receptor antagonist
0,488  0,047  Antineoplastic (lung cancer)
0,438  0,003  Farnesoid X receptor antagonist
0,452  0,029  Radioprotector
0,451  0,031  Antineoplastic (melanoma)
0,465  0,051  Antibacterial
0,408  0,005  Psychosexual dysfunction treatment
0,403  0,001  Glycine receptor agonist
0,437  0,036  CYP2D6 substrate
0,403  0,008  Protein kinase stimulant
0,407  0,014  Muscle relaxant
0,396  0,004  Choleretic
0,386  0,005  Liver cirrhosis treatment
0,413  0,033  Antioxidant
0,383  0,003  Actinic keratosis treatment
0,433  0,054  Antileukemic
0,413  0,035  ICAM1 expression inhibitor
0,380  0,008  Antiviral (Influenza A)
0,399  0,035  UGT1A9 substrate
0,389  0,026  Antineoplastic (renal cancer)
0,376  0,014  Antiviral (Influenza)
0,365  0,004  LDLR expression enhancer
0,362  0,004  ABCA1 expression enhancer
0,365  0,010  Liver fibrosis treatment
0,428  0,079  Alzheimer's disease treatment
0,358  0,011  UGT2B15 substrate
0,358  0,015  Diabetic retinopathy treatment
0,360  0,017  Platelet adhesion inhibitor
0,375  0,041  Antineoplastic (glioma)
0,361  0,029  Angiogenesis stimulant
0,363  0,034  Antineoplastic (lymphoma)
0,332  0,005  Alcohol dehydrogenase substrate
0,330  0,003  CDC25A inhibitor
0,364  0,040  Antidiabetic (type 2)
0,357  0,035  Cardiodepressant
0,358  0,036  Hypoglycemic
0,314  0,000  Hedgehog signaling activator
0,349  0,040  Antipyretic
0,363  0,055  Caspase 3 stimulant
0,380  0,074  Antiobesity
0,310  0,004  UGT2B10 substrate
0,333  0,029  Antineoplastic (sarcoma)
0,341  0,037  Antineoplastic (endocrine cancer)
0,341  0,038  Myocardial infarction treatment
0,311  0,009  Endometrios treatment
0,320  0,021  Male reproductive disfunction treatment
0,302  0,005  Estrogen agonist
0,298  0,002  RNA-directed RNA polymerase stimulant
0,294  0,002  Arachidonic acid antagonist
0,312  0,020  Melanin inhibitor
0,322  0,030  Wound healing agent
0,293  0,003  Anticholelithogenic
0,344  0,054  Antineoplastic (brain cancer)
0,298  0,010  Antifungal enhancer
0,307  0,023  Antiviral (Herpes)
0,323  0,041  Antineoplastic (glioblastoma multiforme)
0,287  0,009  Neurotrophic factor
0,291  0,019  Muscular dystrophy treatment
0,290  0,021  Neurotrophic factor enhancer
0,276  0,007  Contraceptive male
0,269  0,007  Antineoplastic, alkylator
0,312  0,054  Antineoplastic (cervical cancer)
0,285  0,028  Antialcoholic
0,304  0,050  Antidiabetic symptomatic
0,249  0,003  Hyperparathyroidism treatment
0,247  0,003  Liver X receptor beta agonist
0,248  0,005  Postmenopausal disorders treatment
0,246  0,004  Lanosterol 14 alpha demethylase inhibitor
0,305  0,063  Hypoxia-inducible factor 1 alpha inhibitor
0,245  0,004  Liver X receptor agonist
0,263  0,024  NOS3 expression enhancer
0,302  0,065  Antineoplastic (multiple myeloma)
0,259  0,023  Bone formation stimulant
0,282  0,049  Antiulcerative
0,251  0,020  Toxic, respiratory center
0,234  0,003  Glycine receptor antagonist
0,251  0,020  Antidiabetic (type 1)
0,284  0,056  Cytostatic
0,230  0,004  Hypercalcemia treatment
0,243  0,018  Protein-tyrosine phosphatase 1B inhibitor
0,270  0,047  Antihypertriglyceridemic
0,230  0,007  Aromatase inhibitor
0,279  0,058  Vascular (periferal) disease treatment
0,267  0,046  Antiviral (HIV)
0,239  0,022  Antidiarrheal
0,215  0,003  UGT2B11 substrate
0,240  0,029  Carcinogenic, group 3
0,213  0,003  Anabolic
0,235  0,032  Skeletal muscle relaxant
0,237  0,034  Diabetic nephropathy treatment
0,237  0,034  Protein-tyrosine phosphatase inhibitor
0,203  0,001  Cholesterol absorption inhibitor
0,203  0,003  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,208  0,010  AMP-activated protein kinase stimulant
0,285  0,087  Antineoplastic (colorectal cancer)
0,276  0,078  5 Hydroxytryptamine release stimulant
0,229  0,032  Antipruritic
0,209  0,013  Growth stimulant
0,202  0,013  Estrogen antagonist
0,271  0,086  Antineoplastic (colon cancer)
0,269  0,085  CYP1A2 substrate
0,232  0,048  P-glycoprotein inhibitor
0,243  0,060  EphB2 antagonist
0,184  0,003  Na+ K+ transporting ATPase inhibitor
0,236  0,057  Mutagenic
0,180  0,002  Vitamin D receptor antagonist
0,191  0,022  Microtubule formation inhibitor
0,173  0,005  Estrogen receptor alpha agonist
0,206  0,038  Neuropathy treatment
0,202  0,037  Skin whitener
0,256  0,093  Cardioprotectant
0,171  0,008  Paget's disease treatment
0,239  0,078  Antiprotozoal (Leishmania)
0,170  0,012  Inducible nitric-oxide synthase inhibitor
0,160  0,005  CDC25B inhibitor
0,165  0,011  SULT1E1 substrate
0,187  0,037  Skin irritative effect
0,154  0,007  Estrogen receptor beta agonist
0,198  0,052  Eye irritation, high
0,171  0,026  SULT1A1 substrate
0,269  0,125  Calcium channel activator
0,149  0,005  Aldosterone antagonist
0,215  0,073  Antineoplastic enhancer
0,149  0,008  Cushing's syndrome treatment
0,188  0,047  Lipid peroxidase inhibitor
0,172  0,032  Antihemorrhagic
0,165  0,028  Antineoplastic antibiotic
0,161  0,031  Menstruation disorders treatment
0,142  0,013  Estrogen receptor alpha antagonist
0,204  0,077  Psychostimulant
0,213  0,087  Free radical scavenger
0,128  0,003  Farnesoid X receptor agonist
0,142  0,018  Estrogen receptor beta antagonist
0,150  0,028  Antineoplastic alkaloid
0,204  0,083  VCAM1 expression inhibitor
0,174  0,053  Insulin secretagoues
0,128  0,007  Progesterone antagonist
0,216  0,096  Tumour necrosis factor alpha release inhibitor
0,176  0,058  Interleukin 6 antagonist
0,120  0,003  Lipocortins synthesis agonist
0,117  0,001  Vitamin D receptor agonist
0,226  0,111  Gastrin inhibitor
0,252  0,141  Stroke treatment
0,122  0,013  SULT1A2 substrate
0,183  0,078  Antihelmintic
0,106  0,005  Glucocorticoid antagonist
0,103  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,261  0,162  CYP2C19 inhibitor
0,172  0,073  Antineoplastic (bone cancer)
0,102  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,115  0,018  Premenstrual syndrome treatment
0,131  0,034  Toll-Like receptor 4 antagonist
0,135  0,039  HDL-cholesterol increasing
0,098  0,004  Parathyroid hormone antagonist
0,127  0,040  Neutropenia treatment
0,133  0,048  Glutathione S-transferase substrate
0,144  0,061  Antieczematic
0,094  0,012  SULT2A1 substrate
0,136  0,056  Anesthetic local
0,089  0,009  Postcoital contraceptive
0,088  0,009  Mineralocorticoid receptor antagonist
0,152  0,073  Acute respiratory distress syndrome (ARDS) treatment
0,192  0,118  Antihypotensive
0,194  0,120  DNA damaging
0,132  0,058  Antiviral (Hepatitis B)
0,073  0,004  HMG CoA reductase inhibitor
0,113  0,044  Prolactin inhibitor
0,071  0,003  Ileal bile acid transport inhibitor
0,125  0,061  Proteasome inhibitor
0,080  0,019  Andropause treatment
0,158  0,098  Sleep disorders treatment
0,125  0,066  Aldehyde dehydrogenase inhibitor
0,081  0,022  Nitric oxide donor
0,181  0,124  Cardiovascular analeptic
0,085  0,029  HIV-1 integrase (Strand Transfer) inhibitor
0,111  0,055  Protease inhibitor
0,122  0,066  Alkylator
0,060  0,004  CYP24 inhibitor
0,112  0,057  Expectorant
0,167  0,113  Antiparasitic
0,063  0,008  Hypogonadism treatment
0,142  0,088  Thrombolytic
0,178  0,126  Age-related macular degeneration treatment
0,057  0,006  Estrone sulfatase inhibitor
0,089  0,042  Estrogen-related receptor beta agonist
0,094  0,046  Transcription factor NF kappa B stimulant
0,182  0,135  Spasmolytic
0,069  0,022  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,065  0,018  Anesthetic inhalation
0,180  0,133  RNA-directed DNA polymerase inhibitor
0,122  0,076  Cyclooxygenase 3 inhibitor
0,075  0,029  Interferon inducer
0,049  0,005  Glucocorticoid agonist
0,133  0,090  Antifungal (Cryptococcus)
0,046  0,003  Corticosteroid-like
0,098  0,056  Posttraumatic stress disorder treatment
0,084  0,043  Antibiotic
0,068  0,028  Heme oxygenase stimulant
0,043  0,005  Progesterone agonist
0,046  0,010  Ceramide glucosyltransferase inhibitor
0,037  0,004  Apical sodium codependent bile acid transporter inhibitor
0,061  0,029  Acetyl-CoA transferase inhibitor
0,054  0,023  Microtubule stabilization
0,035  0,006  1,3-Beta-glucan synthase inhibitor
0,080  0,052  Interferon agonist
0,102  0,075  Mucolytic
0,061  0,037  Botulinum neurotoxin type A inhibitor
0,100  0,076  Monophenol monooxygenase inhibitor
0,153  0,130  Insulin sensitizer
0,076  0,053  Antitreponemal
0,084  0,063  Ornithine decarboxylase inhibitor
0,161  0,140  Antineoplastic (non-small cell lung cancer)
0,152  0,132  CYP2B6 inhibitor
0,054  0,035  Heparanase inhibitor
0,020  0,001  Transcortin receptor antagonist
0,116  0,098  Vanilloid 1 agonist
0,021  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,045  0,028  HIV-1 protease inhibitor
0,180  0,164  Antihypoxic
0,125  0,109  Phospholipase A2 inhibitor
0,130  0,116  Uterine stimulant
0,020  0,008  Telomerase stimulant
0,061  0,052  Neuraminidase (influenza) inhibitor
0,009  0,002  Vitamin D-like
0,030  0,023  Liver X receptor antagonist
0,108  0,104  Interleukin 4 antagonist
0,042  0,038  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor

